nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Epirubicin—peripheral nervous system neoplasm	0.304	0.433	CbGbCtD
Fluticasone Propionate—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0754	0.107	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0754	0.107	CbGbCtD
Fluticasone Propionate—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0565	0.0806	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0346	0.0493	CbGbCtD
Fluticasone Propionate—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0346	0.0493	CbGbCtD
Fluticasone Propionate—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.026	0.037	CbGbCtD
Fluticasone Propionate—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0238	0.0339	CbGbCtD
Fluticasone Propionate—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0237	0.0338	CbGbCtD
Fluticasone Propionate—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.022	0.0314	CbGbCtD
Fluticasone Propionate—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0101	0.0144	CbGbCtD
Fluticasone Propionate—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00927	0.0132	CbGbCtD
Fluticasone Propionate—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00633	0.00902	CbGbCtD
Fluticasone Propionate—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000552	0.391	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.000322	0.228	CrCbGaD
Fluticasone Propionate—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000256	0.182	CrCbGaD
Fluticasone Propionate—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000202	0.000679	CcSEcCtD
Fluticasone Propionate—Infection—Vincristine—peripheral nervous system neoplasm	0.000202	0.000678	CcSEcCtD
Fluticasone Propionate—Diabetes mellitus—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000671	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000199	0.000669	CcSEcCtD
Fluticasone Propionate—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000667	CcSEcCtD
Fluticasone Propionate—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000198	0.000666	CcSEcCtD
Fluticasone Propionate—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.000661	CcSEcCtD
Fluticasone Propionate—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000197	0.000661	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00066	CcSEcCtD
Fluticasone Propionate—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000194	0.000653	CcSEcCtD
Fluticasone Propionate—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000194	0.000652	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000194	0.000651	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000194	0.000651	CcSEcCtD
Fluticasone Propionate—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000649	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000645	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000192	0.000644	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00019	0.000639	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00019	0.000639	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000631	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000188	0.000631	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000629	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000187	0.000628	CcSEcCtD
Fluticasone Propionate—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000627	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000625	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000624	CcSEcCtD
Fluticasone Propionate—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000185	0.000623	CcSEcCtD
Fluticasone Propionate—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000185	0.000622	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000185	0.000622	CcSEcCtD
Fluticasone Propionate—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.000618	CcSEcCtD
Fluticasone Propionate—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000184	0.000618	CcSEcCtD
Fluticasone Propionate—Malaise—Etoposide—peripheral nervous system neoplasm	0.000182	0.000611	CcSEcCtD
Fluticasone Propionate—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.00061	CcSEcCtD
Fluticasone Propionate—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000609	CcSEcCtD
Fluticasone Propionate—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00018	0.000606	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.000604	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.000604	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000603	CcSEcCtD
Fluticasone Propionate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000179	0.000603	CcSEcCtD
Fluticasone Propionate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000603	CcSEcCtD
Fluticasone Propionate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000178	0.000599	CcSEcCtD
Fluticasone Propionate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000178	0.000599	CcSEcCtD
Fluticasone Propionate—Betamethasone—ABCB1—peripheral nervous system neoplasm	0.000177	0.126	CrCbGaD
Fluticasone Propionate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000177	0.000594	CcSEcCtD
Fluticasone Propionate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000177	0.000594	CcSEcCtD
Fluticasone Propionate—Rash—Topotecan—peripheral nervous system neoplasm	0.000177	0.000594	CcSEcCtD
Fluticasone Propionate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000176	0.000593	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000176	0.000592	CcSEcCtD
Fluticasone Propionate—Cough—Etoposide—peripheral nervous system neoplasm	0.000176	0.000591	CcSEcCtD
Fluticasone Propionate—Headache—Topotecan—peripheral nervous system neoplasm	0.000175	0.00059	CcSEcCtD
Fluticasone Propionate—Rash—Tretinoin—peripheral nervous system neoplasm	0.000175	0.000589	CcSEcCtD
Fluticasone Propionate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.000589	CcSEcCtD
Fluticasone Propionate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000175	0.000589	CcSEcCtD
Fluticasone Propionate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000175	0.000589	CcSEcCtD
Fluticasone Propionate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000175	0.000589	CcSEcCtD
Fluticasone Propionate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000174	0.000586	CcSEcCtD
Fluticasone Propionate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000174	0.000586	CcSEcCtD
Fluticasone Propionate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000174	0.000585	CcSEcCtD
Fluticasone Propionate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000174	0.000585	CcSEcCtD
Fluticasone Propionate—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000174	0.000585	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000584	CcSEcCtD
Fluticasone Propionate—Pain—Vincristine—peripheral nervous system neoplasm	0.000173	0.000583	CcSEcCtD
Fluticasone Propionate—Rash—Melphalan—peripheral nervous system neoplasm	0.000173	0.000581	CcSEcCtD
Fluticasone Propionate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000173	0.000581	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000579	CcSEcCtD
Fluticasone Propionate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000171	0.000577	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00017	0.000573	CcSEcCtD
Fluticasone Propionate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000169	0.00057	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000564	CcSEcCtD
Fluticasone Propionate—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000563	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000167	0.000563	CcSEcCtD
Fluticasone Propionate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000167	0.000563	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00056	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00056	CcSEcCtD
Fluticasone Propionate—Nausea—Topotecan—peripheral nervous system neoplasm	0.000166	0.000559	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000166	0.000558	CcSEcCtD
Fluticasone Propionate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000165	0.000555	CcSEcCtD
Fluticasone Propionate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000165	0.000555	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000164	0.000553	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000163	0.00055	CcSEcCtD
Fluticasone Propionate—Infection—Etoposide—peripheral nervous system neoplasm	0.000163	0.000549	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000163	0.000548	CcSEcCtD
Fluticasone Propionate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000163	0.000548	CcSEcCtD
Fluticasone Propionate—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000545	CcSEcCtD
Fluticasone Propionate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00016	0.000539	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00016	0.000539	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00016	0.000539	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000538	CcSEcCtD
Fluticasone Propionate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00016	0.000537	CcSEcCtD
Fluticasone Propionate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000156	0.000524	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000155	0.000523	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000522	CcSEcCtD
Fluticasone Propionate—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000522	CcSEcCtD
Fluticasone Propionate—Pain—Cisplatin—peripheral nervous system neoplasm	0.000153	0.000516	CcSEcCtD
Fluticasone Propionate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000508	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000506	CcSEcCtD
Fluticasone Propionate—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000504	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000149	0.000503	CcSEcCtD
Fluticasone Propionate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000501	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000497	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000147	0.000493	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000491	CcSEcCtD
Fluticasone Propionate—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000145	0.000489	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000486	CcSEcCtD
Fluticasone Propionate—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000486	CcSEcCtD
Fluticasone Propionate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000144	0.000486	CcSEcCtD
Fluticasone Propionate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000485	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.000484	CcSEcCtD
Fluticasone Propionate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000143	0.000482	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000477	CcSEcCtD
Fluticasone Propionate—Pain—Etoposide—peripheral nervous system neoplasm	0.000141	0.000473	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000472	CcSEcCtD
Fluticasone Propionate—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000469	CcSEcCtD
Fluticasone Propionate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000139	0.000468	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000139	0.000467	CcSEcCtD
Fluticasone Propionate—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000458	CcSEcCtD
Fluticasone Propionate—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000456	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000135	0.000455	CcSEcCtD
Fluticasone Propionate—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000455	CcSEcCtD
Fluticasone Propionate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000135	0.000454	CcSEcCtD
Fluticasone Propionate—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000452	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000134	0.000452	CcSEcCtD
Fluticasone Propionate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000134	0.000451	CcSEcCtD
Fluticasone Propionate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000134	0.00045	CcSEcCtD
Fluticasone Propionate—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000449	CcSEcCtD
Fluticasone Propionate—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000134	0.000449	CcSEcCtD
Fluticasone Propionate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000446	CcSEcCtD
Fluticasone Propionate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000133	0.000446	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000132	0.000445	CcSEcCtD
Fluticasone Propionate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000132	0.000444	CcSEcCtD
Fluticasone Propionate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000131	0.000439	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00013	0.000437	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00013	0.000437	CcSEcCtD
Fluticasone Propionate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000437	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000434	CcSEcCtD
Fluticasone Propionate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000129	0.000434	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000433	CcSEcCtD
Fluticasone Propionate—Rash—Vincristine—peripheral nervous system neoplasm	0.000128	0.00043	CcSEcCtD
Fluticasone Propionate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000128	0.00043	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000429	CcSEcCtD
Fluticasone Propionate—Headache—Vincristine—peripheral nervous system neoplasm	0.000127	0.000427	CcSEcCtD
Fluticasone Propionate—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000424	CcSEcCtD
Fluticasone Propionate—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000422	CcSEcCtD
Fluticasone Propionate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000421	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000123	0.000413	CcSEcCtD
Fluticasone Propionate—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000408	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000121	0.000407	CcSEcCtD
Fluticasone Propionate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000121	0.000405	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000405	CcSEcCtD
Fluticasone Propionate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000401	CcSEcCtD
Fluticasone Propionate—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.0004	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000397	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000394	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000393	CcSEcCtD
Fluticasone Propionate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000116	0.000391	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00039	CcSEcCtD
Fluticasone Propionate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000114	0.000384	CcSEcCtD
Fluticasone Propionate—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000382	CcSEcCtD
Fluticasone Propionate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000113	0.00038	CcSEcCtD
Fluticasone Propionate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000113	0.00038	CcSEcCtD
Fluticasone Propionate—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00038	CcSEcCtD
Fluticasone Propionate—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00038	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000112	0.000378	CcSEcCtD
Fluticasone Propionate—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000377	CcSEcCtD
Fluticasone Propionate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000374	CcSEcCtD
Fluticasone Propionate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000109	0.000366	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000365	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000364	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000364	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00036	CcSEcCtD
Fluticasone Propionate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000358	CcSEcCtD
Fluticasone Propionate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000358	CcSEcCtD
Fluticasone Propionate—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000354	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000352	CcSEcCtD
Fluticasone Propionate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000104	0.000351	CcSEcCtD
Fluticasone Propionate—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000351	CcSEcCtD
Fluticasone Propionate—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000351	CcSEcCtD
Fluticasone Propionate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000349	CcSEcCtD
Fluticasone Propionate—Rash—Etoposide—peripheral nervous system neoplasm	0.000104	0.000349	CcSEcCtD
Fluticasone Propionate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000104	0.000348	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.000103	0.0731	CrCbGaD
Fluticasone Propionate—Headache—Etoposide—peripheral nervous system neoplasm	0.000103	0.000346	CcSEcCtD
Fluticasone Propionate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000342	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000338	CcSEcCtD
Fluticasone Propionate—Palpitations—Epirubicin—peripheral nervous system neoplasm	9.97e-05	0.000335	CcSEcCtD
Fluticasone Propionate—Cough—Epirubicin—peripheral nervous system neoplasm	9.85e-05	0.000331	CcSEcCtD
Fluticasone Propionate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	9.84e-05	0.000331	CcSEcCtD
Fluticasone Propionate—Nausea—Etoposide—peripheral nervous system neoplasm	9.76e-05	0.000328	CcSEcCtD
Fluticasone Propionate—Hypertension—Epirubicin—peripheral nervous system neoplasm	9.75e-05	0.000328	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	9.69e-05	0.000326	CcSEcCtD
Fluticasone Propionate—Chest pain—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000323	CcSEcCtD
Fluticasone Propionate—Arthralgia—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000323	CcSEcCtD
Fluticasone Propionate—Agitation—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.000323	CcSEcCtD
Fluticasone Propionate—Anxiety—Epirubicin—peripheral nervous system neoplasm	9.58e-05	0.000322	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	9.54e-05	0.000321	CcSEcCtD
Fluticasone Propionate—Discomfort—Epirubicin—peripheral nervous system neoplasm	9.49e-05	0.000319	CcSEcCtD
Fluticasone Propionate—Malaise—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000317	CcSEcCtD
Fluticasone Propionate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	9.4e-05	0.000316	CcSEcCtD
Fluticasone Propionate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	9.23e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Oedema—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.00031	CcSEcCtD
Fluticasone Propionate—Infection—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000308	CcSEcCtD
Fluticasone Propionate—Cough—Doxorubicin—peripheral nervous system neoplasm	9.11e-05	0.000307	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000304	CcSEcCtD
Fluticasone Propionate—Hypertension—Doxorubicin—peripheral nervous system neoplasm	9.02e-05	0.000303	CcSEcCtD
Fluticasone Propionate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000302	CcSEcCtD
Fluticasone Propionate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000301	CcSEcCtD
Fluticasone Propionate—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.000299	CcSEcCtD
Fluticasone Propionate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	8.86e-05	0.000298	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	8.83e-05	0.000297	CcSEcCtD
Fluticasone Propionate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	8.78e-05	0.000295	CcSEcCtD
Fluticasone Propionate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	8.7e-05	0.000292	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000287	CcSEcCtD
Fluticasone Propionate—Oedema—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000287	CcSEcCtD
Fluticasone Propionate—Infection—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000285	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000282	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000281	CcSEcCtD
Fluticasone Propionate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.00028	CcSEcCtD
Fluticasone Propionate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.000278	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000276	CcSEcCtD
Fluticasone Propionate—Pain—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000265	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000261	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	7.6e-05	0.000256	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000255	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.000253	CcSEcCtD
Fluticasone Propionate—Urticaria—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000246	CcSEcCtD
Fluticasone Propionate—Pain—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	7.28e-05	0.000245	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000236	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000234	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	6.79e-05	0.000228	CcSEcCtD
Fluticasone Propionate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000228	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000227	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	6.74e-05	0.000227	CcSEcCtD
Fluticasone Propionate—Pruritus—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000219	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.000212	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	6.28e-05	0.000211	CcSEcCtD
Fluticasone Propionate—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000205	CcSEcCtD
Fluticasone Propionate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.03e-05	0.000203	CcSEcCtD
Fluticasone Propionate—Vomiting—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.000197	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000196	CcSEcCtD
Fluticasone Propionate—Rash—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000195	CcSEcCtD
Fluticasone Propionate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000195	CcSEcCtD
Fluticasone Propionate—Headache—Epirubicin—peripheral nervous system neoplasm	5.77e-05	0.000194	CcSEcCtD
Fluticasone Propionate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	5.64e-05	0.00019	CcSEcCtD
Fluticasone Propionate—Nausea—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.000184	CcSEcCtD
Fluticasone Propionate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000182	CcSEcCtD
Fluticasone Propionate—Rash—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000181	CcSEcCtD
Fluticasone Propionate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000181	CcSEcCtD
Fluticasone Propionate—Headache—Doxorubicin—peripheral nervous system neoplasm	5.34e-05	0.00018	CcSEcCtD
Fluticasone Propionate—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.06e-05	0.00017	CcSEcCtD
